Re-TURBT
Second Resection to Ensure Complete Tumour Removal and Accurate Staging
What is Re-TURBT?
Re-TURBT is a planned second transurethral resection of the bladder performed 2–6 weeks after the initial TURBT. It is recommended for high-grade T1 tumours, absence of detrusor muscle in the first specimen, large or multifocal tumours, or incomplete initial resection. Re-TURBT detects residual disease, upstages pathology in 20–40% of cases, and improves treatment decisions before committing to cystectomy or BCG therapy. The procedure is performed under general or spinal anaesthesia with a hospital stay of 1 Day. Success rates reach >85% in appropriately selected patients at experienced centres.
How the Procedure Works
Timing
Re-TURBT is planned 4–6 weeks after the initial TURBT — sufficient time for post-operative bladder oedema to resolve.
Bladder Inspection
With the patient in lithotomy under anaesthesia, a continuous-flow resectoscope is passed and the entire bladder mucosa inspected systematically.
Re-Resection of Original Site
The previous resection site is re-resected completely, taking fresh chips of the original base and lateral margins for histology.
Mapping Biopsies
Any new or suspicious areas of urothelium identified elsewhere in the bladder are biopsied for completeness.
Catheter & Discharge
Haemostasis secured; Ellik evacuator clears all chips; three-way catheter placed; patient typically discharged the following morning.
Outcomes
Who Needs This Treatment?
- →Re-TURBT is mandated for all T1 high-grade (T1G3) bladder cancer at 4–6 weeks after the first resection.
- →Staging accuracy: upstaging to T2 occurs in 20–40% — changing management from BCG to cystectomy.
- →Re-TURBT should always include resection of the original scar and surrounding mucosa.
- →Photodynamic diagnosis (blue-light cystoscopy) at Re-TURBT improves detection of flat CIS lesions.
- →Re-TURBT for Ta low-grade tumours is not routinely required unless resection was incomplete.
- →Results of Re-TURBT directly determine the treatment pathway — BCG vs radical cystectomy.
"Re-TURBT is not optional for high-grade T1 bladder cancer — it is mandatory. The upstaging rate of 20–40% means we frequently change our management plan, protecting patients from inappropriate treatment."
— — Dr. Vipin Reddy, Consultant Urologist, Andrologist & Renal Transplant Surgeon
Common Questions
Frequently Asked
Not sure which treatment is right for you?
Book a consultation with Dr. Vipin Reddy and get a personalised treatment plan.